KEVLIPAR Trademark

Trademark Overview

On Thursday, January 9, 2020, a trademark application was filed for KEVLIPAR with the United States Patent and Trademark Office. The USPTO has given the KEVLIPAR trademark a serial number of 88752683. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 26, 2023. This trademark is owned by AbbVie Inc.. The KEVLIPAR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
kevlipar

General Information

Serial Number88752683
Word MarkKEVLIPAR
Filing DateThursday, January 9, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 26, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 31, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, January 14, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAbbVie Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNorth Chicago, IL 60064
Party NameAbbVie Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNorth Chicago, IL 60064

Trademark Events

Event DateEvent Description
Monday, June 26, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, June 26, 2023ABANDONMENT - NO USE STATEMENT FILED
Saturday, December 3, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 2, 2022SOU EXTENSION 5 GRANTED
Monday, November 21, 2022SOU EXTENSION 5 FILED
Friday, December 2, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, November 21, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, May 3, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, May 1, 2022SOU EXTENSION 4 GRANTED
Sunday, May 1, 2022SOU EXTENSION 4 FILED
Sunday, May 1, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, November 24, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 22, 2021SOU EXTENSION 3 GRANTED
Monday, November 22, 2021SOU EXTENSION 3 FILED
Monday, November 22, 2021SOU TEAS EXTENSION RECEIVED
Saturday, May 22, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 20, 2021SOU EXTENSION 2 GRANTED
Thursday, May 20, 2021SOU EXTENSION 2 FILED
Thursday, May 20, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, November 24, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 20, 2020SOU EXTENSION 1 GRANTED
Friday, November 20, 2020SOU EXTENSION 1 FILED
Friday, November 20, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, May 26, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 31, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 31, 2020PUBLISHED FOR OPPOSITION
Wednesday, March 11, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 25, 2020LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, February 24, 2020ASSIGNED TO LIE
Wednesday, February 12, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 11, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 11, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 11, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, January 27, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, January 27, 2020NON-FINAL ACTION E-MAILED
Monday, January 27, 2020NON-FINAL ACTION WRITTEN
Monday, January 27, 2020ASSIGNED TO EXAMINER
Tuesday, January 14, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, January 13, 2020NEW APPLICATION ENTERED

Related Keywords

kevlipar gastrointestinal hormonal neurological respiratory ophthalmic dermatological psychiatric diseases disorders related